Rossari Biotech Ltd (IN:ROSSARI)
:ROSSARI
Want to see IN:ROSSARI full AI Analyst Report?
Total Valuation
Rossari Biotech Ltd has a market cap or net worth of ₹26.59B. The enterprise value is ₹30.05B.
Market Cap₹26.59B
Enterprise Value₹30.05B
Share Statistics
Rossari Biotech Ltd has 55,383,366 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding55,383,366
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Rossari Biotech Ltd’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 8.37%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)8.37%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee53.25M
Profits Per Employee3.32M
Employee Count450
Asset Turnover1.05
Inventory Turnover4.70
Valuation Ratios
The current PE Ratio of Rossari Biotech Ltd is 11.4. Rossari Biotech Ltd’s PEG ratio is 1.51.
PE Ratio11.4
PS Ratio0.87
PB Ratio1.57
Price to Fair Value1.57
Price to FCF-9.55
Price to Operating Cash Flow-106.30
PEG Ratio1.51
Income Statement
In the last 12 months, Rossari Biotech Ltd had revenue of 23.96B and earned 1.49B in profits. Earnings per share was 26.95.
Revenue23.96B
Gross Profit4.94B
Operating Income2.07B
Pretax Income2.03B
Net Income1.49B
EBITDA2.86B
Earnings Per Share (EPS)26.95
Cash Flow
In the last 12 months, operating cash flow was -250.32M and capital expenditures -1.42B, giving a free cash flow of -1.67B billion.
Operating Cash Flow-250.32M
Free Cash Flow-1.67B
Free Cash Flow per Share-30.12
Dividends & Yields
Rossari Biotech Ltd pays an annual dividend of ₹0.5, resulting in a dividend yield of 0.09%
Dividend Per Share₹0.5
Dividend Yield0.09%
Payout Ratio2.03%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.87
52-Week Price Change-28.07%
50-Day Moving Average472.68
200-Day Moving Average590.90
Relative Strength Index (RSI)65.68
Average Volume (3m)2.66K
Important Dates
Rossari Biotech Ltd upcoming earnings date is Jul 27, 2026, TBA (Confirmed).
Last Earnings DateApr 27, 2026
Next Earnings DateJul 27, 2026
Ex-Dividend Date―
Financial Position
Rossari Biotech Ltd as a current ratio of 1.57, with Debt / Equity ratio of 32.69%
Current Ratio1.57
Quick Ratio1.05
Debt to Market Cap0.20
Net Debt to EBITDA1.20
Interest Coverage Ratio7.24
Taxes
In the past 12 months, Rossari Biotech Ltd has paid 533.02M in taxes.
Income Tax533.02M
Effective Tax Rate0.26
Enterprise Valuation
Rossari Biotech Ltd EV to EBITDA ratio is 8.53, with an EV/FCF ratio of -11.12.
EV to Sales1.02
EV to EBITDA8.53
EV to Free Cash Flow-11.12
EV to Operating Cash Flow54.02
Balance Sheet
Rossari Biotech Ltd has ₹719.76M in cash and marketable securities with ₹3.53B in debt, giving a net cash position of -₹2.81B billion.
Cash & Marketable Securities₹719.76M
Total Debt₹3.53B
Net Cash-₹2.81B
Net Cash Per Share-₹50.68
Tangible Book Value Per Share₹200.38
Margins
Gross margin is 22.91%, with operating margin of 8.63%, and net profit margin of 6.23%.
Gross Margin22.91%
Operating Margin8.63%
Pretax Margin8.45%
Net Profit Margin6.23%
EBITDA Margin11.93%
EBIT Margin8.63%
Analyst Forecast
The average price target for Rossari Biotech Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast15.19%
EPS Growth Forecast9.27%